New research on transcaval TAVR was presented today which demonstrated a new approach to performing transcatheter aortic valve replacement (TAVR) to be safe and effective for patients who may otherwise have very limited options. Oklahoma Heart Institute (OHI) was one of three top medical centers in the U.S. who enrolled patients in the study.
“We continue to strive to bring the latest techniques and cutting edge technologies in cardiovascular care to our patients at OHI so that they receive the best and most comprehensive care.” says Dr. Kamran Muhammad, an Oklahoma Heart Institute physician and one of the authors of the study.
The research was presented today at the leading international cardiology meeting, the Transcatheter Cardiovascular Therapeutics (TCT) Scientific Sessions. It is so important that it was simultaneously published in a top scientific cardiology journal, The Journal of the American College of Cardiology (JACC).
To learn more about Oklahoma Heart Institute and the TAVR procedure, please click here.
